Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase
- 15 December 2009
- journal article
- Published by Springer Nature in Journal of Molecular Modeling
- Vol. 16 (6) , 1169-1178
Abstract
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are allosteric inhibitors of the HIV-1 reverse transcriptase. Recently a series of Triazolinone and Pyridazinone were reported as potent inhibitors of HIV-1 wild type reverse transcriptase. In the present study, docking and 3D quantitative structure activity relationship (3D QSAR) studies involving comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were performed on 31 molecules. Ligands were built and minimized using Tripos force field and applying Gasteiger-Hückel charges. These ligands were docked into protein active site using GLIDE 4.0. The docked poses were analyzed; the best docked poses were selected and aligned. CoMFA and CoMSIA fields were calculated using SYBYL6.9. The molecules were divided into training set and test set, a PLS analysis was performed and QSAR models were generated. The model showed good statistical reliability which is evident from the $ {\text{r}}_{\text{nv}}^{\text{2}} $ , $ {\text{q}}_{\text{loo}}^{\text{2}} $ and $ {\text{r}}_{\text{pred}}^2 $ values. The CoMFA model provides the most significant correlation of steric and electrostatic fields with biological activities. The CoMSIA model provides a correlation of steric, electrostatic, acceptor and hydrophobic fields with biological activities. The information rendered by 3D QSAR model initiated us to optimize the lead and design new potential inhibitors. Figure
Docked pose of most potent molecule and newly designed molecule in the protein active site, showing hydrophobic cavity and hydrogen bond interaction with Lys103
Keywords
This publication has 11 references indexed in Scilit:
- Design of Annulated Pyrazoles as Inhibitors of HIV-1 Reverse TranscriptaseJournal of Medicinal Chemistry, 2008
- Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 2008
- Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 2008
- Probing nonnucleoside inhibitor‐induced active‐site distortion in HIV‐1 reverse transcriptase by transient kinetic analysesProtein Science, 2007
- HIV-1 RT Nonnucleoside Inhibitors and Their Interaction with RT for Antiviral Drug DevelopmentInfectious Disorders - Drug Targets, 2006
- HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistanceTrends in Pharmacological Sciences, 2005
- Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological ActivityJournal of Medicinal Chemistry, 1994
- Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteinsJournal of the American Chemical Society, 1988
- Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR StudiesQuantitative Structure-Activity Relationships, 1988
- Iterative partial equalization of orbital electronegativity—a rapid access to atomic chargesTetrahedron, 1980